The evolving landscape of systemic treatment for advanced hepatocellular carcinoma and biliary tract cancer

Saved in:
Bibliographic Details
Published inCancer treatment and research communications Vol. 27; p. 100360
Main Author Rizzo, Alessandro
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 2021
Elsevier
Subjects
Antineoplastic Agents - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biliary Tract Neoplasms - drug therapy
Carcinoma, Hepatocellular - drug therapy
Humans
Immune Checkpoint Inhibitors - administration & dosage
Immune Checkpoint Inhibitors - therapeutic use
Isocitrate Dehydrogenase - antagonists & inhibitors
Liver Neoplasms - drug therapy
Molecular Targeted Therapy
Protein Kinase Inhibitors - administration & dosage
Protein Kinase Inhibitors - therapeutic use
Receptors, Fibroblast Growth Factor - antagonists & inhibitors
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Commentary-2
content type line 23
ObjectType-Review-1
ObjectType-Editorial-3
ISSN:2468-2942
2468-2942
DOI:10.1016/j.ctarc.2021.100360